Successful dalbavancin use in preventing reactivation of Staphylococcus aureus liver abscess during pre-engraftment neutropenia after allogeneic hematopoietic stem cell transplantation.
Successful dalbavancin use in preventing reactivation of Staphylococcus aureus liver abscess during pre-engraftment neutropenia after allogeneic hematopoietic stem cell transplantation.
J Chemother. 2021 Jan 18;:1-2
Authors: Dell'Orso G, Faraci M, Giardino S, Mariani M, Mesini A, Castagnola E
PMID: 33459210 [PubMed - as supplied by publisher]
Source: Journal of Chemotherapy - Category: Cancer & Oncology Tags: J Chemother Source Type: research
More News: Cancer & Oncology | Chemotherapy | Liver | Liver Transplant | Staphylococcus Aureus | Stem Cell Therapy | Stem Cells | Transplants | Urology & Nephrology